trial · primary record
Methotrexate Injection
Proliferative Vitreoretinopathy
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 860 |
| Primary completion | 2028-12 |
| Primary endpoint | Primary Outcome Measure |
| Registry ID | NCT06541574 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:44.291Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06541574
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.